PL337940A1 - Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma - Google Patents

Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma

Info

Publication number
PL337940A1
PL337940A1 PL98337940A PL33794098A PL337940A1 PL 337940 A1 PL337940 A1 PL 337940A1 PL 98337940 A PL98337940 A PL 98337940A PL 33794098 A PL33794098 A PL 33794098A PL 337940 A1 PL337940 A1 PL 337940A1
Authority
PL
Poland
Prior art keywords
prostaglandines
exhibiting
derivatives
useful
side effects
Prior art date
Application number
PL98337940A
Other languages
English (en)
Inventor
Johan Stjernschantz
Bahram Resul
Staffan Lake
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL337940(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of PL337940A1 publication Critical patent/PL337940A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL98337940A 1997-07-11 1998-07-10 Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma PL337940A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702706A SE9702706D0 (sv) 1997-07-11 1997-07-11 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma

Publications (1)

Publication Number Publication Date
PL337940A1 true PL337940A1 (en) 2000-09-11

Family

ID=20407743

Family Applications (1)

Application Number Title Priority Date Filing Date
PL98337940A PL337940A1 (en) 1997-07-11 1998-07-10 Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma

Country Status (19)

Country Link
EP (1) EP1014991A1 (is)
JP (1) JP2002509543A (is)
KR (1) KR20010021682A (is)
CN (1) CN1169528C (is)
AU (1) AU739828B2 (is)
BR (1) BR9815501A (is)
CA (1) CA2294779A1 (is)
HK (1) HK1029942A1 (is)
HU (1) HUP0003106A3 (is)
IL (1) IL133871A (is)
IS (1) IS5333A (is)
NO (1) NO20000062D0 (is)
NZ (1) NZ501834A (is)
PL (1) PL337940A1 (is)
RU (1) RU2207858C2 (is)
SE (1) SE9702706D0 (is)
SK (1) SK183499A3 (is)
TR (1) TR200000008T2 (is)
WO (1) WO1999002165A1 (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803761D0 (sv) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
AU766163B2 (en) 1999-03-05 2003-10-09 Duke University C16 unsaturated fp-selective prostaglandins analogs
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
AU2003299137A1 (en) * 2002-09-16 2004-04-23 Texas Tech University System Inhibition of metallo-beta-lactamase
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
EP2305304A4 (en) 2008-04-28 2011-08-10 Nat University Corp Hamamatsu University School Of Medicine IMMUNOSTIMULATOR WITH EP1 AGONIST
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
ES2672624T3 (es) 2009-05-01 2018-06-15 Aerie Pharmaceuticals, Inc. Inhibidores de mecanismo doble para el tratamiento de enfermedades
WO2011046569A1 (en) * 2009-10-16 2011-04-21 Cayman Chemical Company Process for the preparation of f-series prostaglandins
DK2831077T3 (en) 2012-03-28 2016-08-15 Merck Patent Gmbh BICYCLIC PYRAZINO DERIVATIVES
JP2012246301A (ja) * 2012-08-10 2012-12-13 Cayman Chemical Co Inc Ｆ系プロスタグランジン類を調製する方法
PL3811943T3 (pl) 2013-03-15 2023-06-12 Aerie Pharmaceuticals, Inc. Związek do stosowania w leczeniu zaburzeń oczu
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
JP6907319B2 (ja) 2016-08-31 2021-07-21 アエリエ ファーマシューティカルズ インコーポレイテッド 眼科用組成物
CA3057872A1 (en) 2017-03-31 2018-10-04 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds
CA3112391A1 (en) 2018-09-14 2020-03-19 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
ES2105333T3 (es) * 1992-10-13 1997-10-16 Alcon Lab Inc Combinaciones de prostaglandinas y derivados de clonidina para el tratamiento del glaucoma.

Also Published As

Publication number Publication date
TR200000008T2 (tr) 2000-05-22
AU739828B2 (en) 2001-10-18
SE9702706D0 (sv) 1997-07-11
NZ501834A (en) 2002-05-31
NO20000062L (no) 2000-01-06
KR20010021682A (ko) 2001-03-15
AU8368398A (en) 1999-02-08
RU2207858C2 (ru) 2003-07-10
WO1999002165A1 (en) 1999-01-21
HK1029942A1 (en) 2001-04-20
HUP0003106A3 (en) 2002-12-28
HUP0003106A2 (hu) 2001-01-29
NO20000062D0 (no) 2000-01-06
CN1262623A (zh) 2000-08-09
SK183499A3 (en) 2000-07-11
IS5333A (is) 2000-01-07
IL133871A0 (en) 2001-04-30
IL133871A (en) 2004-09-27
CN1169528C (zh) 2004-10-06
EP1014991A1 (en) 2000-07-05
BR9815501A (pt) 2001-07-17
CA2294779A1 (en) 1999-01-21
JP2002509543A (ja) 2002-03-26

Similar Documents

Publication Publication Date Title
PL337940A1 (en) Derivatives of prostaglandines exhibiting not any side effects, useful in treating glaucoma
IS1995B (is) Tríazól afleiður, gagnlegar í meðhöndlun
GB9723365D0 (en) Derivatives of 6,8-Difluoro-7-Hydroxycoumarin
HK1075043A1 (en) Antivirally active heterocyclic azahexane derivatives
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
PL336290A1 (en) Sulphonamides for treating endothelin-involving disorders
IL126095A0 (en) Azolobenzazepine derivatives as neurogically active agents
HU9800138D0 (en) 8-substituted-1,3,8-triaza-spiro [4,5]-decan-4-on derivatives
HUP9900790A3 (en) Imidazoquinazoline derivatives
EP1007028A4 (en) TREATING GLAUCOMA WITH 8 ISO PROSTAGLANDINE
PL330277A1 (en) Derivatives of 2,4-diaminopyrimidine
HU9601565D0 (en) N-acyl-(2-aryl-cyclopropyl-methyl)-amine derivatives
PL342060A1 (en) Derivatives of 1,3,4-oxadiaxolone
PL341318A1 (en) Derivatives of indole useful in treating oesteoporosis
EP0881878A4 (en) ARYLHYDRAZONE DERIVATIVES AS AN ANTIBACTERIAL AGENT
HUP9801565A3 (en) Benzimidazole derivatives
GB9405400D0 (en) Taxane derivatives
HUP9902883A3 (en) Bis/acridinecarboxamide/ and bis/phenazinecarboxamide/ derivatives as antitumour agents, preparation and use thereof
HUP0001792A3 (en) Dibenzo-oxazepine and-dioxepine derivatives and their use as anti-tumor agents
AU3564597A (en) Transmitter-receiver pair
EP0910356A4 (en) BIPHENYLAMIDO DERIVATIVES AS MELATONERGIC AGENTS
GB9508748D0 (en) Benzimidazole derivatives
AU7799898A (en) Compositions and methods for treating glaucoma
AU9160498A (en) Use of sulfated glycosaminoglycans for treating of retinopathy
ZA968069B (en) Sulfonamide derivatives